Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 33Fallopian Tube Neoplasms 21Endometrial Neoplasms 17Uterine Cervical Neoplasms 13Colorectal Neoplasms 12Neoplasm Metastasis 10Pancreatic Neoplasms 9Prostatic Neoplasms 8Melanoma 8Lung Neoplasms 8Carcinoma, Renal Cell 7Stomach Neoplasms 6Carcinosarcoma 6Carcinoma, Hepatocellular 6Carcinoma, Transitional Cell 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Esophageal Neoplasms 4Sarcoma 3Rectal Neoplasms 3Colonic Neoplasms 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Pelvic Neoplasms 2

Interventions

Paclitaxel 24Carboplatin 21Taxes 15Bevacizumab 9Cisplatin 7Immunoglobulin G 6Disulfides 6Topotecan 3Docetaxel 3paclitaxel poliglumex 2VTX-2337 2SS1(dsFv)PE38 2Platinum 2Peripheral Blood Stem Cell Transplantation 2Gemcitabine 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Chemotherapy, Adjuvant 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1trioctyl phosphine oxide 1sargramostim 1pegfilgrastim 1liposomal doxorubicin 1emactuzumab 1elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1belinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brenner Tumor × Specimen Handling × Gynecologic × Clear all
NCT02068794 2025-11-18

MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Mayo Clinic

Phase 1/2 Active not recruiting
34 enrolled 12 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡